Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DTOX - CITA BIOMEDICAL, ULTRA RAPID OPIATE DETOXIFICATION -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (18)	2/16/1999 10:13:00 AM
From: Cisco	Respond to of 96

New Center Opens: New CITA Treatment Center Opens in New Jersey PR Newswire - February 16, 1999 06:16 BEVERLY HILLS, Calif., Feb. 16 /PRNewswire/ -- CITA BIOMEDICAL INC. (OTC Bulletin Board: DTOX) announced today that its proprietary CITA/UROD treatment program is now operational on the premises of Pascack Valley Hospital in Westwood, New Jersey. The new center is within easy reach of nearby New York City. The unique CITA/UROD procedure has successfully treated over 5,000 patients throughout Europe and the Middle East, and more than 700 in the U.S., where the procedure is performed by CITA-certified anesthesiologists in a CITA-authorized hospital while the patient is asleep under anesthesia. Most patients require no more than a 24-hour hospital stay. Two recent studies have indicated that the CITA/UROD program produces outstanding results for its clients. The first-ever long-term study was released last summer. It concluded that 55% of addicted persons treated with the CITA/UROD procedure in 1996 were relapse-free after six months, compared to only 10-20% of those who were treated by traditional methods. A second study examining the CITA/UROD program in 1998 reported success rates approaching 70% for patients evaluated six months after treatment, reflecting an ongoing commitment by the company to enhance the effectiveness of its services. CITA Biomedical Inc. now has three treatment centers offering its programs. The other locations include the University of Illinois Medical Center in Chicago and Mount Sinai Medical Center in Miami Beach. SOURCE CITA Biomedical Inc. /CONTACT: Joseph V. Dunn, President of CITA Biomedical Inc., 310-550-4965, or Investor Relations for CITA Biomedical Inc., 310-550-4971/ /Web site: citabio.com (DTOX)